Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)
Clinical trial NCT04127578 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04127578
- Sponsor
- Prevail Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-03
- Primary completion
- 2031-03-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.